Literature DB >> 17088691

Comparisons between Alzheimer disease, frontotemporal lobar degeneration, and normal aging with brain mapping.

Jennifer L Whitwell1, Clifford R Jack.   

Abstract

Alzheimer disease (AD) and frontotemporal lobar degeneration (FTLD) are both common degenerative dementias in the under 65 age group. Although clinical criteria have been defined for both diseases, there is considerable overlap in clinical features, and hence, diagnosis still can be very difficult particularly in the early stages of the disease. As a result, there has been increasing interest in using magnetic resonance imaging to better characterize these diseases and to aid in diagnosis. Voxel-based morphometry (VBM) is an automated technique that assesses patterns of regional gray matter atrophy on magnetic resonance imaging between 2 groups of subjects. It is unbiased in that it looks throughout the whole brain and does not require any a priori assumptions concerning which structures to assess, giving it a significant advantage over traditional region of interest-based methods. Voxel-based morphometry has been widely used to assess patterns of regional atrophy in subjects with AD and FTLD. These studies have demonstrated specific patterns of regional loss in both diseases, compared the 2 diseases to look for differences that could be diagnostically useful, and have correlated regions of gray matter loss to cognitive and behavioral deficits in these subjects. This article will review the findings of these studies and discuss the role of VBM in these neurodegenerative diseases.

Entities:  

Mesh:

Year:  2005        PMID: 17088691     DOI: 10.1097/01.rmr.0000245457.98029.e1

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  32 in total

1.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls.

Authors:  Jonathan H Morra; Zhuowen Tu; Liana G Apostolova; Amity E Green; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Arthur W Toga; Clifford R Jack; Norbert Schuff; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2008-11-08       Impact factor: 6.556

2.  Structural brain changes in normal individuals with a maternal history of Alzheimer's.

Authors:  Valentina Berti; Lisa Mosconi; Lidia Glodzik; Yi Li; John Murray; Susan De Santi; Alberto Pupi; Wai Tsui; Mony J De Leon
Journal:  Neurobiol Aging       Date:  2011-02-12       Impact factor: 4.673

3.  The effect of amyloid pathology and glucose metabolism on cortical volume loss over time in Alzheimer's disease.

Authors:  Sofie M Adriaanse; Koene R A van Dijk; Rik Ossenkoppele; Martin Reuter; Nelleke Tolboom; Marissa D Zwan; Maqsood Yaqub; Ronald Boellaard; Albert D Windhorst; Wiesje M van der Flier; Philip Scheltens; Adriaan A Lammertsma; Frederik Barkhof; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-11       Impact factor: 9.236

Review 4.  Atrophy: When too much atrophy is too little brain.

Authors:  Charles A J Romanowski; Iain D Wilkinson
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

5.  Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies.

Authors:  Tomonori Kanda; Kazunari Ishii; Takafumi Uemura; Naokazu Miyamoto; Toshiki Yoshikawa; Atsushi K Kono; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-26       Impact factor: 9.236

6.  Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis.

Authors:  Brian B Avants; Philip A Cook; Lyle Ungar; James C Gee; Murray Grossman
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

7.  Concordance and discordance between brain perfusion and atrophy in frontotemporal dementia.

Authors:  Soichiro Shimizu; Yu Zhang; Joel Laxamana; Bruce L Miller; Joel H Kramer; Michael W Weiner; Norbert Schuff
Journal:  Brain Imaging Behav       Date:  2010-03       Impact factor: 3.978

8.  CSF Biomarkers for Alzheimer's Disease Diagnosis.

Authors:  A Anoop; Pradeep K Singh; Reeba S Jacob; Samir K Maji
Journal:  Int J Alzheimers Dis       Date:  2010-06-23

9.  Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  G D Rabinovici; W W Seeley; E J Kim; M L Gorno-Tempini; K Rascovsky; T A Pagliaro; S C Allison; C Halabi; J H Kramer; J K Johnson; M W Weiner; M S Forman; J Q Trojanowski; S J Dearmond; B L Miller; H J Rosen
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Dec-2008 Jan       Impact factor: 2.035

Review 10.  Review of MR elastography applications and recent developments.

Authors:  Kevin J Glaser; Armando Manduca; Richard L Ehman
Journal:  J Magn Reson Imaging       Date:  2012-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.